|
Summary Information: Design Therapeutics Inc. Common Stock NASDAQ:DSGN |
  [email protected] |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Design Therapeutics is a biotechnology company developing a new class of therapies based on a platform of gene targeted chimera (GeneTAC™) small molecules. The company’s lead program is focused on the treatment of Friedreich ataxia, followed by a program in myotonic dystrophy type-1 and discovery efforts for multiple other serious degenerative disorders caused by nucleotide repeat expansions.
__The following are links to various summary and news pages for __Design Therapeutics Inc. Common Stock [ DSGN ]. __Note: Some Links might not have information for the company. |
|